Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ONCOLYS-BIOPHARMA-INC-15147937/news/Oncolys-BioPharma-First-Patient-Dosed-in-NRG-Oncology-Phase-I-Clinical-Trial-for-Telomelysin-OBP-3-37230514/?utm_source=whatsapp&utm_medium=social&utm_campaign=share